5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
| Autor: | Han-Kun Hao, Sarbani Adhikari, Ziwen Liu, Ge Chen, Xiaoping Qian, Yanqun Song, Zhongguang Luo, Yaping Wang, Marc Bissonnette, Xingyu Lu, Wei Zhang, Chuan He, Jie Liu, Wanwei Zheng, Lei You, Jun Zhang, Jianping Shi, Quan Liao, Luchun Hua, Lian-Huan Wei, Shulin Yu, Yuanqiang Dong, Katherine Meckel, Fen Luo, Xin-Xiang Zhang, Ming Cui, Zhang Xu, Wenshuai Li, Peng Wang, Ji Nie, Jun Hong, Yupei Zhao, Taiping Zhang, Guifang Jia, Fang Yuan, Menghua Dai, Diannan Xu |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
biology liquid biopsy Cell Biology Bioinformatics circulating cell-free DNA 5hmC-Seal Circulating Cell-Free DNA Chromatin cancer biomarker 03 medical and health sciences genomic DNA 030104 developmental biology Histone biology.protein Human genome Original Article Epigenetics 5-hydroxymethylcytosine Liquid biopsy Molecular Biology Epigenomics |
| Zdroj: | Cell Research |
| ISSN: | 1748-7838 1001-0602 |
| Popis: | DNA modifications such as 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are epigenetic marks known to affect global gene expression in mammals. Given their prevalence in the human genome, close correlation with gene expression and high chemical stability, these DNA epigenetic marks could serve as ideal biomarkers for cancer diagnosis. Taking advantage of a highly sensitive and selective chemical labeling technology, we report here the genome-wide profiling of 5hmC in circulating cell-free DNA (cfDNA) and in genomic DNA (gDNA) of paired tumor and adjacent tissues collected from a cohort of 260 patients recently diagnosed with colorectal, gastric, pancreatic, liver or thyroid cancer and normal tissues from 90 healthy individuals. 5hmC was mainly distributed in transcriptionally active regions coincident with open chromatin and permissive histone modifications. Robust cancer-associated 5hmC signatures were identified in cfDNA that were characteristic for specific cancer types. 5hmC-based biomarkers of circulating cfDNA were highly predictive of colorectal and gastric cancers and were superior to conventional biomarkers and comparable to 5hmC biomarkers from tissue biopsies. Thus, this new strategy could lead to the development of effective, minimally invasive methods for diagnosis and prognosis of cancer from the analyses of blood samples. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|